Filing Details

Accession Number:
0001104659-20-035949
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-19 17:00:54
Reporting Period:
2020-03-17
Accepted Time:
2020-03-19 17:00:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1722964 Y-Mabs Therapeutics Inc. YMAB Pharmaceutical Preparations (2834) 474619612
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1753222 Juan Claus Pedro Moller-San C/o Y-Mabs Therapeutics, Inc.
230 Park Avenue, Suite 3350
New York NY 10169
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-03-17 1,900 $17.22 1,900 No 4 P Indirect By minor child
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By minor child
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 857,303 Indirect By CM Holding 2015 ApS
Common Stock 15,625 Direct
Footnotes
  1. Reporting Person may be deemed to have a pecuniary interest in the securities due to family relationship.
  2. Reporting Person disclaims beneficial ownership of the securities reported and this report shall not be deemed an admission that Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  3. CM Holding 2015 ApS is Reporting Person's personal holding company of which Reporting Person is the sole owner and as such Reporting Person has sole voting and dispositive power with respect to such shares.